How My Friend Lost $32,000 Holding Novo Nordisk (Don’t Make His Mistake)

Click here to accept Marketing cookies and load this content

My friend Sven turned $100,000 into $68,000 by making one critical mistake: holding Novo Nordisk without proper risk management. This painful story shows exactly why stop-losses and exit strategies are essential for protecting your capital and your confidence.

In April 2023, Sven bought Novo Nordisk at $79.19, riding the obesity drug revolution wave. When the stock hit $130, he was up $64,000 and felt invincible. But instead of protecting his gains, he held on… and watched it all disappear.

Today, Novo Nordisk sits at $54, and Sven has lost over $31,000. But the real damage isn’t just financial – it’s the confidence crisis that comes from riding a winner all the way back to a loser.

This video breaks down exactly what went wrong and shows you two simple risk management strategies that could have saved Sven thousands of dollars and preserved his trading confidence.

Don’t let overconfidence destroy your portfolio like it did Sven’s.

Timestamps:
0:00 The $100,000 Novo Nordisk disaster begins
0:28 April 2023: The perfect setup that fooled everyone
0:46 Why the fundamentals looked unstoppable
1:12 The euphoric ride to $130 and $64K in gains
1:32 Sven’s peak confidence and biggest mistake
2:24 The greed that killed his profits
2:57 2025 reality check: When everything went wrong
3:15 From $64K gains to $31K losses – the brutal math
3:41 The confidence crisis that’s worse than the money
4:17 What Sven should have done: Two life-saving scenarios
4:50 The trailing stop-loss that would have saved $31K
5:11 The painful lesson Novo Nordisk taught Sven
5:51 The silver lining: Henrik’s friends who listened
6:28 Final thoughts: Discipline beats conviction every time

Key Lessons:
✅ Always use stop-losses to protect gains
✅ Take profits when you’re ahead
✅ Discipline beats conviction in trading
✅ Protect capital first, profits second
❌ Never let euphoria override risk management